CARL (Carlsmed, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Carlsmed, Inc. Common Stock (CARL) is a publicly traded Healthcare sector company. As of May 21, 2026, CARL trades at $11.79 with a market cap of $297.13M and a P/E ratio of -5.59. CARL moved +4.07% today. Year to date, CARL is -2.65%; over the trailing twelve months it is flat. Its 52-week range spans $8.50 to $17.19. Analyst consensus is strong buy with an average price target of $18.40. Rallies surfaces CARL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CARL stock?
Hedge funds tracked by Rallies that own CARL include Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Carlsmed, Inc. Common Stock.
CARL Key Metrics
Key financial metrics for CARL
Metric
Value
Price
$11.79
Market Cap
$297.13M
P/E Ratio
-5.59
EPS
$-2.12
Dividend Yield
0.00%
52-Week High
$17.19
52-Week Low
$8.50
Volume
268.50K
Avg Volume
0
Revenue (TTM)
$50.51M
Net Income
$-29.63M
Gross Margin
75.31%
Top Hedge Funds Holding CARL
Orbimed Advisors holds 1.25M shares of CARL, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own CARL include Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Carlsmed, Inc. Common Stock.
Does Rallies show 13F holders for CARL?
Yes. Rallies tracks hedge fund and 13F ownership data for CARL, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CARL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CARL. It does not provide personalized investment advice.
